The water samples were evaluated for plaque-forming viruses on the specific algal host, and the plaque isolates were chosen based on phenotypic characteristics of interest or for geographic distribution purposes.
Many types of mouthrinse active ingredients have been evaluated for their plaque- reducing effectiveness and ability to reduce mutans streptococci, including chlorhexidine, essential oils, triclosan, cetylpyridinium chloride, sanquinarin, sodium dodecyl sulphate, and various metal ions (tin, zinc, copper).
Nanoparticles (10 80 nm, with or without polysaccharide coating), or silver nitrate (AgNO3) at concentrations of 100, 50, 25, and 12.5 μg/mL were evaluated for efficacy using a plaque reduction assay.
Coronary computed tomography angiography (CCTA) has been recently evaluated for its ability to assess coronary plaque characteristics, including plaque composition.
Each specimen was evaluated for the presence of atherosclerotic plaque.
Standard IVUS indices were evaluated for volume index (volume/length), and plaque components were measured by IB-IVUS for percent tissue volume.
Then, interpretable segments were evaluated for the presence of atherosclerotic plaques.
Thereafter, all interpretable segments were evaluated for the presence of any atherosclerotic plaque [31] using axial images and curved multiplanar reconstructions.
Even though adalimumab has only been evaluated for up to 100 weeks for chronic plaque psoriasis, the efficacy and safety of adalimumab therapy has been evaluated up to 120 weeks for PsA.
Several promising agents have been synthesized and evaluated for in vivo imaging probes of β-amyloid plaques in Alzheimer's disease (AD) brain.
